BioLife Solutions, Inc. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
BioLife Solutions, Inc. (BLFS) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2022-11-09
- BioLife Solutions, Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2021-12-31 was $0.00.
- BioLife Solutions, Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2021-09-30 was $31.98M.
- BioLife Solutions, Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2020-12-31 was $0.00.
- BioLife Solutions, Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2021 was $264.72M.
- BioLife Solutions, Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2020 was $0.00.
- BioLife Solutions, Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2019 was $0.00.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $31.98M derived: sum of 2 quarters · filed 2022-11-09 | $264.72M 10-K · filed 2022-03-31 | |
| 2021-09-30 | $31.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $264.72M 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $232.74M 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | -$19.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 | ||
| 2019-09-30 | $19.93M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |